Bone loss in SpA appears to be less pronounced than that observed in RA, also because anti-citrullinated antibodies (ACPA) induce osteoclastogenesis even in the absence of inflammation and are associated with systemic bone loss in RA before the onset of clinical disease [126]. This evidence concerns the gene PRTN3 and rheumatoid arthritis.